HEADER HYDROLASE/HYDROLASE INHIBITOR 31-DEC-11 3VB6 TITLE CRYSTAL STRUCTURE OF SARS-COV 3C-LIKE PROTEASE WITH C6Z COMPND MOL_ID: 1; COMPND 2 MOLECULE: 3C-LIKE PROTEINASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: 3CL-PRO, 3CLP; COMPND 5 EC: 3.4.22.-; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: C6Z INHIBITOR; COMPND 9 CHAIN: E, F; COMPND 10 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: SARS CORONAVIRUS; SOURCE 3 ORGANISM_COMMON: SARS-COV; SOURCE 4 ORGANISM_TAXID: 227859; SOURCE 5 GENE: 1A; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 OTHER_DETAILS: SYNTHETIC INHIBITOR KEYWDS HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.P.CHUCK,K.B.WONG REVDAT 4 06-NOV-24 3VB6 1 REMARK REVDAT 3 06-DEC-23 3VB6 1 REMARK REVDAT 2 08-NOV-23 3VB6 1 REMARK LINK REVDAT 1 12-DEC-12 3VB6 0 JRNL AUTH C.P.CHUCK,C.CHEN,Z.KE,D.C.-C.WAN,H.F.CHOW,K.B.WONG JRNL TITL DESIGN, SYNTHESIS AND CRYSTALLOGRAPHIC ANALYSIS OF JRNL TITL 2 NITRILE-BASED BROAD-SPECTRUM PEPTIDOMIMETIC INHIBITORS FOR JRNL TITL 3 CORONAVIRUS 3C-LIKE PROTEASES JRNL REF EUR.J.MED.CHEM. V. 59C 1 2012 JRNL REFN ISSN 0223-5234 JRNL PMID 23202846 JRNL DOI 10.1016/J.EJMECH.2012.10.053 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.99 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.490 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 22556 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.193 REMARK 3 R VALUE (WORKING SET) : 0.188 REMARK 3 FREE R VALUE : 0.245 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 8.860 REMARK 3 FREE R VALUE TEST SET COUNT : 1999 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 28.9875 - 6.0089 0.99 1505 146 0.1933 0.2102 REMARK 3 2 6.0089 - 4.7763 1.00 1473 143 0.1874 0.2164 REMARK 3 3 4.7763 - 4.1746 1.00 1482 145 0.1504 0.2242 REMARK 3 4 4.1746 - 3.7938 1.00 1465 142 0.1690 0.2101 REMARK 3 5 3.7938 - 3.5224 1.00 1475 144 0.1957 0.2429 REMARK 3 6 3.5224 - 3.3150 1.00 1473 142 0.1873 0.2498 REMARK 3 7 3.3150 - 3.1492 1.00 1458 142 0.1925 0.2719 REMARK 3 8 3.1492 - 3.0123 1.00 1473 144 0.1780 0.2445 REMARK 3 9 3.0123 - 2.8964 1.00 1443 141 0.1788 0.2401 REMARK 3 10 2.8964 - 2.7966 1.00 1481 144 0.2113 0.3209 REMARK 3 11 2.7966 - 2.7092 1.00 1454 141 0.2219 0.3298 REMARK 3 12 2.7092 - 2.6318 1.00 1470 142 0.2431 0.2938 REMARK 3 13 2.6318 - 2.5626 1.00 1462 142 0.2324 0.3094 REMARK 3 14 2.5626 - 2.5001 1.00 1443 141 0.2172 0.3077 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.39 REMARK 3 B_SOL : 40.36 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.370 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.770 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 34.48 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.44 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 3.66690 REMARK 3 B22 (A**2) : 5.43770 REMARK 3 B33 (A**2) : -9.10460 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 7.54770 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.008 4869 REMARK 3 ANGLE : 1.129 6615 REMARK 3 CHIRALITY : 0.072 750 REMARK 3 PLANARITY : 0.005 858 REMARK 3 DIHEDRAL : 14.232 1756 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3VB6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 01-FEB-12. REMARK 100 THE DEPOSITION ID IS D_1000069824. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-OCT-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E+ SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : YALE MIRRORS REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS IV REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 22586 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 29.610 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 100.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASES REMARK 200 STARTING MODEL: PDB ENTRY 2Q6G REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.51 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 8.5% PEG 6000, 0.1M MES, 1MM DTT, 1MM REMARK 280 EDTA, 3% DMSO, 10% GLYCEROL, PH 5.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 289K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 48.21750 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4610 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25170 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 REMARK 400 THE C6Z INHIBITOR IS PEPTIDE-LIKE, A MEMBER OF ENZYME INHIBITOR REMARK 400 CLASS. REMARK 400 REMARK 400 GROUP: 1 REMARK 400 NAME: C6Z INHIBITOR REMARK 400 CHAIN: E, F REMARK 400 COMPONENT_1: PEPTIDE LIKE POLYMER REMARK 400 DESCRIPTION: NULL REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 302 REMARK 465 VAL A 303 REMARK 465 THR A 304 REMARK 465 PHE A 305 REMARK 465 GLN A 306 REMARK 465 PHQ E 1 REMARK 465 THR E 2 REMARK 465 SER E 3 REMARK 465 PHQ F 1 REMARK 465 THR F 2 REMARK 465 SER F 3 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 5 99.81 -69.09 REMARK 500 ASP A 33 -116.39 60.67 REMARK 500 ASN A 51 55.73 -171.26 REMARK 500 ASN A 84 -120.89 47.19 REMARK 500 TYR A 154 -105.57 87.70 REMARK 500 ALA A 191 30.97 -99.75 REMARK 500 LEU A 282 51.66 32.25 REMARK 500 ASP B 33 -133.48 49.84 REMARK 500 ASP B 34 30.04 -98.43 REMARK 500 ILE B 43 20.26 -78.43 REMARK 500 THR B 45 -163.79 -124.75 REMARK 500 ASP B 48 -64.97 -20.54 REMARK 500 MET B 49 -35.30 -36.21 REMARK 500 LEU B 50 -76.25 -44.04 REMARK 500 ASN B 84 -129.64 51.25 REMARK 500 TYR B 154 -112.94 74.85 REMARK 500 THR B 190 -147.86 -111.25 REMARK 500 ARG B 217 14.77 -140.15 REMARK 500 ASN B 238 37.04 70.67 REMARK 500 ASN B 277 -110.13 55.83 REMARK 500 LEU E 6 94.42 -49.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 401 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN E OF C6Z INHIBITOR REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR CHAIN F OF C6Z INHIBITOR REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3VB3 RELATED DB: PDB REMARK 900 RELATED ID: 3VB4 RELATED DB: PDB REMARK 900 RELATED ID: 3VB5 RELATED DB: PDB REMARK 900 RELATED ID: 3VB7 RELATED DB: PDB DBREF 3VB6 A 1 306 UNP P0C6U8 R1A_CVHSA 3241 3546 DBREF 3VB6 B 1 306 UNP P0C6U8 R1A_CVHSA 3241 3546 DBREF 3VB6 E 1 7 PDB 3VB6 3VB6 1 7 DBREF 3VB6 F 1 7 PDB 3VB6 3VB6 1 7 SEQRES 1 A 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 A 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 A 306 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO SEQRES 4 A 306 ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO SEQRES 5 A 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER SEQRES 6 A 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 A 306 GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL SEQRES 8 A 306 ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 A 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 A 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 A 306 ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 A 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 A 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 A 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR SEQRES 15 A 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 A 306 THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU SEQRES 17 A 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 A 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 A 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 A 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 A 306 VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN SEQRES 22 A 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE SEQRES 23 A 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 A 306 CYS SER GLY VAL THR PHE GLN SEQRES 1 B 306 SER GLY PHE ARG LYS MET ALA PHE PRO SER GLY LYS VAL SEQRES 2 B 306 GLU GLY CYS MET VAL GLN VAL THR CYS GLY THR THR THR SEQRES 3 B 306 LEU ASN GLY LEU TRP LEU ASP ASP THR VAL TYR CYS PRO SEQRES 4 B 306 ARG HIS VAL ILE CYS THR ALA GLU ASP MET LEU ASN PRO SEQRES 5 B 306 ASN TYR GLU ASP LEU LEU ILE ARG LYS SER ASN HIS SER SEQRES 6 B 306 PHE LEU VAL GLN ALA GLY ASN VAL GLN LEU ARG VAL ILE SEQRES 7 B 306 GLY HIS SER MET GLN ASN CYS LEU LEU ARG LEU LYS VAL SEQRES 8 B 306 ASP THR SER ASN PRO LYS THR PRO LYS TYR LYS PHE VAL SEQRES 9 B 306 ARG ILE GLN PRO GLY GLN THR PHE SER VAL LEU ALA CYS SEQRES 10 B 306 TYR ASN GLY SER PRO SER GLY VAL TYR GLN CYS ALA MET SEQRES 11 B 306 ARG PRO ASN HIS THR ILE LYS GLY SER PHE LEU ASN GLY SEQRES 12 B 306 SER CYS GLY SER VAL GLY PHE ASN ILE ASP TYR ASP CYS SEQRES 13 B 306 VAL SER PHE CYS TYR MET HIS HIS MET GLU LEU PRO THR SEQRES 14 B 306 GLY VAL HIS ALA GLY THR ASP LEU GLU GLY LYS PHE TYR SEQRES 15 B 306 GLY PRO PHE VAL ASP ARG GLN THR ALA GLN ALA ALA GLY SEQRES 16 B 306 THR ASP THR THR ILE THR LEU ASN VAL LEU ALA TRP LEU SEQRES 17 B 306 TYR ALA ALA VAL ILE ASN GLY ASP ARG TRP PHE LEU ASN SEQRES 18 B 306 ARG PHE THR THR THR LEU ASN ASP PHE ASN LEU VAL ALA SEQRES 19 B 306 MET LYS TYR ASN TYR GLU PRO LEU THR GLN ASP HIS VAL SEQRES 20 B 306 ASP ILE LEU GLY PRO LEU SER ALA GLN THR GLY ILE ALA SEQRES 21 B 306 VAL LEU ASP MET CYS ALA ALA LEU LYS GLU LEU LEU GLN SEQRES 22 B 306 ASN GLY MET ASN GLY ARG THR ILE LEU GLY SER THR ILE SEQRES 23 B 306 LEU GLU ASP GLU PHE THR PRO PHE ASP VAL VAL ARG GLN SEQRES 24 B 306 CYS SER GLY VAL THR PHE GLN SEQRES 1 E 7 PHQ THR SER ALA VAL LEU 0JU SEQRES 1 F 7 PHQ THR SER ALA VAL LEU 0JU HET 0JU E 7 9 HET 0JU F 7 9 HET EDO A 401 4 HETNAM 0JU (4S,5Z)-4-AMINO-5-IMINOPENTANAMIDE HETNAM EDO 1,2-ETHANEDIOL HETSYN EDO ETHYLENE GLYCOL FORMUL 3 0JU 2(C5 H11 N3 O) FORMUL 5 EDO C2 H6 O2 FORMUL 6 HOH *134(H2 O) HELIX 1 1 SER A 10 GLY A 15 1 6 HELIX 2 2 HIS A 41 ILE A 43 5 3 HELIX 3 3 GLU A 47 ASN A 51 5 5 HELIX 4 4 ASN A 53 ARG A 60 1 8 HELIX 5 5 LYS A 61 PHE A 66 5 6 HELIX 6 6 ILE A 200 ASN A 214 1 15 HELIX 7 7 THR A 226 MET A 235 1 10 HELIX 8 8 LYS A 236 ASN A 238 5 3 HELIX 9 9 THR A 243 LEU A 250 1 8 HELIX 10 10 LEU A 250 GLY A 258 1 9 HELIX 11 11 ALA A 260 GLY A 275 1 16 HELIX 12 12 THR A 292 SER A 301 1 10 HELIX 13 13 SER B 10 GLY B 15 1 6 HELIX 14 14 HIS B 41 CYS B 44 5 4 HELIX 15 15 GLU B 47 ASN B 51 5 5 HELIX 16 16 ASN B 53 LYS B 61 1 9 HELIX 17 17 SER B 62 PHE B 66 5 5 HELIX 18 18 ILE B 200 ASN B 214 1 15 HELIX 19 19 THR B 226 MET B 235 1 10 HELIX 20 20 LYS B 236 ASN B 238 5 3 HELIX 21 21 THR B 243 LEU B 250 1 8 HELIX 22 22 LEU B 250 GLY B 258 1 9 HELIX 23 23 ALA B 260 GLY B 275 1 16 HELIX 24 24 THR B 292 CYS B 300 1 9 SHEET 1 A 6 VAL A 73 LEU A 75 0 SHEET 2 A 6 LEU A 67 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 A 6 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 A 6 THR A 25 PRO A 39 -1 O GLY A 29 N VAL A 18 SHEET 5 A 6 LEU A 86 ASN A 95 -1 O VAL A 91 N ASP A 34 SHEET 6 A 6 VAL A 77 GLY A 79 -1 N GLY A 79 O LYS A 90 SHEET 1 B 6 VAL A 73 LEU A 75 0 SHEET 2 B 6 LEU A 67 ALA A 70 -1 N ALA A 70 O VAL A 73 SHEET 3 B 6 MET A 17 CYS A 22 -1 N THR A 21 O LEU A 67 SHEET 4 B 6 THR A 25 PRO A 39 -1 O GLY A 29 N VAL A 18 SHEET 5 B 6 LEU A 86 ASN A 95 -1 O VAL A 91 N ASP A 34 SHEET 6 B 6 MET A 82 GLN A 83 -1 N GLN A 83 O LEU A 86 SHEET 1 C 5 LYS A 100 PHE A 103 0 SHEET 2 C 5 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 C 5 VAL A 148 ASP A 153 -1 N GLY A 149 O TYR A 161 SHEET 4 C 5 THR A 111 TYR A 118 -1 N SER A 113 O PHE A 150 SHEET 5 C 5 SER A 121 ALA A 129 -1 O TYR A 126 N VAL A 114 SHEET 1 D 3 LYS A 100 PHE A 103 0 SHEET 2 D 3 CYS A 156 GLU A 166 1 O VAL A 157 N LYS A 100 SHEET 3 D 3 HIS A 172 THR A 175 -1 O THR A 175 N MET A 162 SHEET 1 E 7 VAL B 73 LEU B 75 0 SHEET 2 E 7 LEU B 67 ALA B 70 -1 N VAL B 68 O LEU B 75 SHEET 3 E 7 MET B 17 CYS B 22 -1 N GLN B 19 O GLN B 69 SHEET 4 E 7 THR B 25 LEU B 32 -1 O LEU B 27 N VAL B 20 SHEET 5 E 7 THR B 35 PRO B 39 -1 O TYR B 37 N LEU B 30 SHEET 6 E 7 LEU B 86 VAL B 91 -1 O LEU B 89 N VAL B 36 SHEET 7 E 7 VAL B 77 GLN B 83 -1 N SER B 81 O ARG B 88 SHEET 1 F 5 TYR B 101 PHE B 103 0 SHEET 2 F 5 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 F 5 VAL B 148 ASP B 153 -1 N ASN B 151 O SER B 158 SHEET 4 F 5 THR B 111 TYR B 118 -1 N SER B 113 O PHE B 150 SHEET 5 F 5 SER B 121 ALA B 129 -1 O SER B 123 N ALA B 116 SHEET 1 G 3 TYR B 101 PHE B 103 0 SHEET 2 G 3 CYS B 156 GLU B 166 1 O PHE B 159 N LYS B 102 SHEET 3 G 3 HIS B 172 THR B 175 -1 O ALA B 173 N MET B 165 LINK SG CYS A 145 C 0JU E 7 1555 1555 1.66 LINK SG CYS B 145 C 0JU F 7 1555 1555 1.68 LINK C LEU E 6 N 0JU E 7 1555 1555 1.33 LINK C LEU F 6 N 0JU F 7 1555 1555 1.34 SITE 1 AC1 5 ARG A 105 HIS A 134 GLY A 183 ASP B 245 SITE 2 AC1 5 ASP B 248 SITE 1 AC2 15 HIS A 41 MET A 49 PHE A 140 LEU A 141 SITE 2 AC2 15 ASN A 142 GLY A 143 SER A 144 CYS A 145 SITE 3 AC2 15 HIS A 163 HIS A 164 MET A 165 GLU A 166 SITE 4 AC2 15 GLN A 189 THR A 190 HOH A 560 SITE 1 AC3 16 HIS B 41 MET B 49 PHE B 140 LEU B 141 SITE 2 AC3 16 GLY B 143 CYS B 145 HIS B 163 HIS B 164 SITE 3 AC3 16 MET B 165 GLU B 166 ARG B 188 GLN B 189 SITE 4 AC3 16 THR B 190 GLN B 192 HOH B 430 HOH F 101 CRYST1 52.096 96.435 67.694 90.00 103.48 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019195 0.000000 0.004600 0.00000 SCALE2 0.000000 0.010370 0.000000 0.00000 SCALE3 0.000000 0.000000 0.015191 0.00000